T7926	PR:000005015 0 6	CARD15
T7927	PR:000011270 7 11	NOD2
T7928	PR:000005015 87 93	CARD15
T7929	PR:000011270 94 98	NOD2
T7930	PR:000004924 206 208	CD
T7931	PR:000008350 213 217	GVHD
T7932	PR:000000123 278 285	patches
T7933	PR:000013056 287 289	PP
T7934	PR:000017209 330 335	Using
T7935	PR:000023369 338 341	new
T7936	PR:000003901 396 404	analysed
T7937	PR:Q6P0D0 409 415	impact
T7938	PR:000010430 513 524	Methodology
T7939	PR:000013039 525 534	Principal
T7940	PR:000013502 583 586	PPs
T7941	PR:000009751 591 594	LFs
T7942	PR:000004555 661 663	At
T7943	PR:000017527 670 671	4
T7944	PR:000022182 735 737	by
T7945	PR:000006090 743 752	cytometry
T7946	PR:000013502 779 782	PPs
T7947	PR:000009415 786 788	KO
T7948	PR 853 854	+
T7949	1 856 857	-
T7950	PR:000009415 864 866	KO
T7951	PR:000024236 872 876	were
T7952	PR:000008989 945 948	IL4
T7953	PR:000022182 958 960	by
T7954	PR:000009167 968 970	In
T7955	PR:000004907 979 980	,
T7956	PR:000014793 1040 1046	spleen
T7957	PR:000009415 1050 1052	KO
T7958	PR:000002183 1059 1061	By
T7959	PR:000005339 1069 1076	chamber
T7960	PR:000008880 1144 1153	increased
T7961	PR:Q9W6A7 1157 1161	both
T7962	PR:000007709 1223 1230	Finally
T7963	PR:000009415 1232 1234	KO
T7964	PR:000005993 1295 1306	Conclusions
T7965	PR:000013050 1314 1315	/
T7966	PR:000022182 1401 1403	by
T7967	PR:000006890 1407 1418	exaggerated
T7968	PR:000016292 1466 1471	These
T7969	PR:000023555 1485 1492	provide
T7970	PR:000011270 1564 1568	NOD2
T7971	PR:000002019 1580 1589	disorders
T7972	PR:000009139 1605 1617	Introduction
T7973	PR:000000364 1627 1638	Recruitment
T7974	PR:000010220 1708 1709	(
T7975	PR:000029205 1713 1714	)
T7976	PR:000011270 1817 1821	NOD2
T7977	PR:000024066 1830 1832	to
T7978	PR:000002059 1884 1886	It
T7979	PR:000022222 1891 1893	be
T7980	PR:000017403 1969 1973	When
T7981	PR:000004907 1983 1984	,
T7982	1 2045 2046	-
T7983	PR:000012270 2049 2056	pathway
T7984	PR:000008443 2118 2122	Half
T7985	PR:000004924 2126 2128	CD
T7986	PR:000015960 2175 2179	Some
T7987	PR:000024065 2183 2186	the
T7988	PR:Q8BH66 11980 11986	Card15
T7989	PR:000011593 11987 11991	Nod2
T7990	PR:000005015 12034 12040	CARD15
T7991	PR:000011270 12041 12045	NOD2
T7992	PR:000022460 13771 13782	development
T7993	PR:000022828 13786 13789	gut
T7994	PR:000015224 13840 13842	on
T7995	1 13847 13848	-
T7996	PR:000005015 19700 19706	CARD15
T7997	PR:000011270 19707 19711	NOD2
T7998	PR:000005431 19936 19945	secondary
T7999	PR:000023493 19949 19958	primitive
T8000	PR:000004123 20024 20033	adherence
T8001	PR:000014793 20037 20045	selected
T8002	PR:000023189 20131 20135	mice
T8003	PR:000022078 20143 20145	an
T8004	PR:000012085 20332 20334	of
T8005	PR 20338 20339	+
T8006	PR:000022990 20427 20429	is
T8007	PR:Q9W6A9 20432 20438	result
T8008	PR:000013050 20587 20588	/
T8009	PR:000009070 20593 20605	invalidation
T8010	PR:000010229 20839 20844	might
T8011	PR:000000794 20848 20857	explained
T8012	PR:000016485 20925 20929	TNBS
T8013	PR:000009070 20930 20937	induced
T8014	PR:000023190 21221 21229	modulate
T8015	PR:000002097 21234 21242	severity
T8016	PR:000024065 21447 21451	that
T8017	PR:000011579 21456 21464	observed
T8018	PR:Q8BH66 21629 21635	Card15
T8019	PR:000011593 21636 21640	Nod2
T8020	PR:000029953 21723 21735	demonstrated
T8021	PR:000022579 21748 21754	factor
T8022	PR:000024065 21897 21901	that
T8023	PR:000006405 21906 21912	defect
T8024	PR:000022990 22037 22039	is
T8025	PR:000017368 22051 22055	with
T8026	PR:000015224 22180 22182	on
T8027	PR:000008653 22187 22192	Human
T8028	PR:000024065 22344 22347	the
T8029	PR:000013050 22354 22355	/
T8030	PR:000004077 31370 31379	annexin V
T8031	PR:000029222 31662 31678	Latifa Ferkdadji
T8032	PR:000007317 31988 31994	12 and
T8033	PR:000017459 32490 32496	WT (â–¡)
T8034	PR:Q8BH66 36278 36284	Card15
T8035	PR:000011593 36285 36289	Nod2
T8036	PR:000013193 36378 36379	.
T8037	PR:000017368 36391 36395	with
T8038	PR:000012190 36717 36720	PCR
T8039	PR:000012085 36729 36731	of
T8040	PR:000009415 36844 36846	KO
T8041	PR:000013193 36851 36852	.
T8042	PR:000022475 37130 37132	de
T8043	PR:000014393 37136 37145	Recherche
